Okyo Pharma Limited ADR (OKYO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | OKYO | AMGN | VRTX | REGN | BMY |
| Company | Okyo Pharma Limited ADR | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 1.4800 | 314.11 | 446.00 | 987.99 | 43.14 |
| High | 1.5500 | 316.67 | 446.39 | 995.92 | 43.43 |
| Low | 1.4800 | 311.90 | 439.90 | 982.97 | 42.54 |
| Last | 1.4900 | 312.99 | 440.33 | 992.56 | 42.55 |
| Change | -0.0300 | -1.55 | -5.54 | +5.29 | -0.81 |
| % Change | -1.97% | -0.49% | -1.24% | +0.54% | -1.87% |
| Volume | 2,300 | 457,957 | 243,876 | 109,972 | 5,574,922 |
| 20-Day Average Volume | 24,730 | 2,769,786 | 1,047,741 | 442,415 | 14,898,196 |
| Previous Close | 1.5200 | 314.54 | 445.87 | 987.27 | 43.36 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.4828 | 297.65 | 416.53 | 947.90 | 44.43 |
| 20-Day Raw Stochastic | 67.85% | 82.34% | 88.26% | 97.45% | 0.15% |
| 20-Day Relative Strength | 50.97% | 63.06% | 67.79% | 63.42% | 29.07% |
| Weighted Alpha | -20.08 | +41.16 | +34.18 | +36.53 | -35.50 |
| Today's Opinion | 40% Sell | 72% Buy | 72% Buy | 88% Buy | 100% Sell |
| Previous Opinion | 24% Sell | 72% Buy | 72% Buy | 100% Buy | 100% Sell |
| Last Month's Opinion | 96% Sell | 40% Sell | 8% Buy | 24% Buy | 88% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.68% since 05/13/24 | +0.37% since 05/14/24 | +2.96% since 05/14/24 | +0.83% since 05/14/24 | -4.72% since 05/14/24 |
| Low | 1.4000 on 05/14/24 | 310.37 on 05/17/24 | 428.62 on 05/15/24 | 966.00 on 05/17/24 | 42.59 on 05/21/24 |
| High | 1.5800 on 05/17/24 | 321.44 on 05/15/24 | 447.85 on 05/20/24 | 995.92 on 05/21/24 | 45.17 on 05/15/24 |
| 1-Month | |||||
| %Chg | +6.22% since 04/19/24 | +16.22% since 04/19/24 | +11.92% since 04/19/24 | +10.71% since 04/19/24 | -12.94% since 04/19/24 |
| Low | 1.3001 on 04/23/24 | 265.72 on 04/26/24 | 391.70 on 04/30/24 | 875.22 on 04/26/24 | 42.59 on 05/21/24 |
| High | 1.5800 on 05/17/24 | 322.60 on 05/03/24 | 447.85 on 05/20/24 | 995.92 on 05/21/24 | 49.56 on 04/22/24 |
| 3-Month | |||||
| %Chg | +2.05% since 02/20/24 | +10.27% since 02/21/24 | +5.15% since 02/21/24 | +4.20% since 02/21/24 | -16.32% since 02/21/24 |
| Low | 1.3000 on 04/12/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 42.59 on 05/21/24 |
| High | 1.9000 on 03/21/24 | 322.60 on 05/03/24 | 447.85 on 05/20/24 | 998.33 on 02/28/24 | 55.03 on 03/13/24 |
| 6-Month | |||||
| %Chg | -13.87% since 11/20/23 | +18.92% since 11/21/23 | +24.38% since 11/21/23 | +24.29% since 11/21/23 | -12.13% since 11/21/23 |
| Low | 1.1900 on 02/02/24 | 260.68 on 04/19/24 | 346.29 on 11/28/23 | 792.57 on 11/28/23 | 42.59 on 05/21/24 |
| High | 2.1200 on 12/19/23 | 329.72 on 02/05/24 | 448.40 on 01/30/24 | 998.33 on 02/28/24 | 55.03 on 03/13/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 42,960 | 168,730,256 | 115,058,088 | 108,783,320 | 87,895,056 |
| Shares Outstanding, K | 28,832 | 536,435 | 258,053 | 110,186 | 2,027,100 |
| Annual Sales | 0 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 45,006,000,000 |
| Annual Net Income | -13,270,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 8,025,000,000 |
| Last Quarter Sales | N/A | 7,447,000,000 | 2,690,600,000 | 3,145,000,000 | 11,865,000,000 |
| Last Quarter Net Income | N/A | -113,000,000 | 1,099,600,000 | 722,000,000 | -11,911,000,000 |
| 60-Month Beta | 0.03 | 0.60 | 0.39 | 0.17 | 0.45 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 3.96 on 05/02/24 | 4.76 on 05/06/24 | 9.55 on 05/02/24 | -4.40 on 04/25/24 |
| Latest Earnings Date | 08/21/23 | 05/02/24 | 05/06/24 | 05/02/24 | 04/25/24 |
| Most Recent Dividend | N/A | 2.250 on 05/16/24 | N/A | N/A | 0.600 on 04/04/24 |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | N/A | 04/04/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.77 | 29.56 | 26.47 | 41.93 |